Institut Curie;INSERM (Institut National de la Sante et de la Recherche Medicale);Centre National de la Recherche Scientifique;Universite d' Aix-Marseille
The invention relates to the use of cystamine, cysteamine, or a salt thereof, or of calcineurin inhibitors for treating a MeCP2-associated disorder such as Rett syndrome.